However, in patients with acute HFrEF, a rise in IL-6 assessed 30 days after enrolment was associated with an increased risk of death.43 By enrolling patients at the time of heart failure hospitalization, we included a population that was more symptomatic and at higher risk of adverse outcomes than the general HFpEF population. This evidence concerns the gene IL6 and heart failure.